If Beyond Lucid Technologies had won last year’s DC to VC competition, more emergency responders dealing with Hurricane Sandy and the Frankenstorm might have be using the company’s software that improves patient handoff from EMT to a hospital’s ER staff.
On any regular day, lack of adequate technology leads to a lot of lost patient data as EMTs transfer patients from the ambulance to the hospital. That risk is magnified during events like hurricanes and storms like Sandy, which is expected to cause untold damage to the East Coast, said Jonathan Feit, co-founder and CEO of Beyond Lucid Technologies. That’s because networks that first responders rely on tend to falter during such disasters.
Feit believes the risk could be reduced if EMTs and other first responders used Beyond Lucid’s MediView Platform.
“Our system is completely independent of network connection,” Feit said in an interview as the storm that was pounding the country’s northeast. “As long as a hospital has computer power, we can get a hard line like an Ethernet cable or a USB and transfer the patient data.”
Feit’s confidence comes from his belief that the Walnut Creek, California-based company’s software system is more resilient than competing software.
“In our case, our platform was designed for maximum stress to the system,” he said. “So our system has the ability to maximize risk reduction. Unlike other providers, our focus has been on disaster management.”
Feit claims that Beyond Lucid was the “first in the industry to integrate online/offline GPS tied to the care record.” The software can also capture images for telehealth and store them locally while most other competing products need an Internet connection to be able to collect and store that image.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Already, Beyond Lucid seems to be winning some accolades. On Oct. 10, Beyond Lucid won the Series A award in the Morganthaler Ventures’ DC to VC competition.
“Emergency Medical Services [personnel] don’t get the credit they deserve,” Feit, who has a military background said. “We want to able to make their lives easier.”
